ERBB2 and neoplasm: The same cytokine induction pattern was observed when Trastuzumab-MCC-CpG conjugate was pre-incubated with HER2-expressing B14.3 HER2 tumor cells before addition of GM-CSF BMDC to the cultures (Fig 2C and 2D).